Integrated care pathway

The current healthcare approach to multimorbidity is fragmented. AFFIRMO aims to move from fragmentation to an integrated pathway designed to be Patient-centred, Systemic and Digital


AFFIRMO's care pathway will account of personal preferences for treatment and considers the social context of patients. The treatment strategy will be the result of a shared decision-making process.


AFFIRMO's care pathway will enable synergies and cooperation among the different health disciplines involved in the treatment of patients with multimorbidity.


AFFIRMO's care pathway will rely on a digital platform, based on open standards, developed to assist physicians in applying and tailoring a personalised care strategy.

The workplan

AFFIRMO’s integrated care pathway will focus on Atrial Fibrillation (AF), a cardiac arrhythmia associated with high risk of morbidity. The workplan is structured around three research areas:

Clusters of multimorbidity

Researchers will characterize how different patterns of multimorbidity are distributed within the population of older individuals with AF.

Combining multiple analysis techniques, the team will investigate the reciprocal relationships between the most common diseases and AF. Drug patterns and potential drug reactions will also be addressed.

Stakeholder involvement

The project will assess the needs of patients, caregivers, and health professionals for the comprehensive management of multimorbidity (including AF) and examines ways of optimizing care and self-management.

Data will be collected though surveys and interviews. The goal is to develop a set of quality performance indicators (QPIs) to support the co-designing process of the care approach proposed by AFFIRMO.

Integrated care pathway

AFFIRMO will develop, implement and test patient-cantered approach on older multimorbid AF patients in the clinical practice. The proposed approach will rely on a digital platform designed to bring patients, caregivers, and health professionals closer together through information sharing.

An international clinic study will be performed to assess the effectiveness of the AFFIRMO’s care approach. Researchers will also consider the economic dimension by identifying how the integrated pathway will impact health outcomes and costs.


A multidisciplinary consortium across Europe representing clinical research, epidemiology, data science, biostatistics, pharmacology, economics, psychology and social sciences.

Check our latest news

Save the Date: EuGMS 18th International Congress!

In less than 20 days, EuGSM – one of AFFIRMO’s partners – will hold an International Congress under the theme “Better Together- Multidisciplinary Team Working”.

Have your say on the development of a new EU Strategy on Global Health!

An open consultation was launched by the European Commission in preparation for a new EU strategy on global health.

AFFIRMO at the International Conference on Communication in Healthcare 2022

An occasion to discuss and receive feedbacks on performed research!

The 2022 Heart Rhythm Congress 2022: registrations are open!

The Arrhythmia Alliance (A-A), one of AFFIRMO’s partners, is organising the Heart Rhythm Congress 2022 (HRC2022), the UK’s largest heart rhythm congress which will take place from 9 to 11 October 2022. There is something for everyone: whatever your role in the healthcare team, there are sessions at HRC that meet your needs and improve your education.